← Leaderboards
Kenneth E White
Indiana University Indianapolis
$12,659,578
Attributed
$15,399,871
Total exposure
12
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.1M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$15,399,871 · 12
By mechanism
R01$10,325,412 · 5
RF1$3,126,515 · 1
R21$1,563,048 · 4
R41$301,892 · 1
F32$83,004 · 1
Top collaborators
- Christian Faul4 shared
- Steven S Welc1 shared
Most similar at Indiana University Indianapolis
Same institution · by research overlap
- Anthony B. Firulli$18,318,152
- Erica L Clinkenbeard$2,166,527
- Emmanuel Solis$65,173
Others in their field
Top investigators on “Kidney”
- Jeffrey P Krischer · University Of South Florida$540,222,210
- John M Lachin · George Washington University$155,894,464
- David M Nathan · Massachusetts Institute Of Technology$127,229,266
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$111,521,899
- David Heimbrook · Leidos Biomedical Research, Inc.$83,221,586
- Peter Scott Heeger · Case Western Reserve University$80,562,246
Research focus
KidneyMolecularInorganic PhosphateIn VivoMetabolismHomeostasisFibroblast Growth Factor 23ReceptorMineralsSignal TransductionFamilial Hypophosphatemic Bone DiseaseOsteomalaciaSerumProductionGenesLeadChronic Kidney FailureRegulationMediatingSyndromeInsightMutationWastingSecondary To
Grant awards (42)
Targeting a novel inter-tissue L-BAIBA/FGF23 axis to enhance adaptive musculoskeletal remodeling in aging$3,126,515
RF1 · FY2025 · AG · contact PI
Directly targeting renal fibrosis in the aged with CKD using in vivo CAR-T cell therapy$431,771
R21 · FY2024 · AG · contact PI
Targeting sKlotho-FGF23 Interactions to Improve Pathological Phosphate Handling in CKD$424,753
R01 · FY2024 · DK · contact PI
Targeting sKlotho-FGF23 Interactions to Improve Pathological Phosphate Handling in CKD$442,453
R01 · FY2023 · DK · contact PI
Novel Therapy for Hyperphosphatemic Familial Tumoral Calcinosis (hfTC) and Generalized Hyperphosphatemia$231,003
R41 · FY2023 · AR · contact PI
Novel Therapy for Hyperphosphatemic Familial Tumoral Calcinosis (hfTC) and Generalized Hyperphosphatemia$70,889
R41 · FY2023 · AR · contact PI
Changes in phosphate metabolism cause pathologic cardiac remodeling in chronic kidney disease (CKD)$584,924
R01 · FY2022 · HL · contact PI
Targeting sKlotho-FGF23 Interactions to Improve Pathological Phosphate Handling in CKD$442,453
R01 · FY2022 · DK · contact PI
Changes in phosphate metabolism cause pathologic cardiac remodeling in chronic kidney disease (CKD)$584,924
R01 · FY2021 · HL · contact PI
Targeting sKlotho-FGF23 Interactions to Improve Pathological Phosphate Handling in CKD$457,078
R01 · FY2021 · DK · contact PI
FGF23 induction in phosphate-responsive single cells$202,943
R21 · FY2021 · AR · contact PI
Changes in phosphate metabolism cause pathologic cardiac remodeling in chronic kidney disease (CKD)$584,924
R01 · FY2020 · HL · contact PI
Novel Control of FGF23 in Metabolic Bone Disease$228,772
R01 · FY2020 · DK · contact PI
FGF23 induction in phosphate-responsive single cells$174,350
R21 · FY2020 · AR · contact PI
Changes in phosphate metabolism cause pathologic cardiac remodeling in chronic kidney disease (CKD)$599,299
R01 · FY2019 · HL · contact PI
Novel Control of FGF23 in Metabolic Bone Disease$232,566
R01 · FY2019 · DK · contact PI
Novel Control of FGF23 in Metabolic Bone Disease$236,250
R01 · FY2018 · DK · contact PI
Control of FGF23 Bioactivity via Circulating alpha-Klotho$339,300
R01 · FY2017 · DK · contact PI
Novel mediators of FGF23 bioactivity$207,900
R21 · FY2017 · AR · contact PI
Control of FGF23 Bioactivity via Circulating alpha-Klotho$339,300
R01 · FY2016 · DK · contact PI
Novel mediators of FGF23 bioactivity$173,250
R21 · FY2016 · AR · contact PI
FGF-23 Regulation of Phosphate Homeostasis$339,300
R01 · FY2015 · DK · contact PI
Control of FGF23 Bioactivity via Circulating alpha-Klotho$339,300
R01 · FY2015 · DK · contact PI
FGF-23 Regulation of Phosphate Homeostasis$339,300
R01 · FY2014 · DK · contact PI
Control of FGF23 Bioactivity via Circulating alpha-Klotho$339,300
R01 · FY2014 · DK · contact PI
Control of FGF23 Bioactivity via Circulating alpha-Klotho$339,300
R01 · FY2013 · DK · contact PI
FGF-23 Regulation of Phosphate Homeostasis$327,425
R01 · FY2013 · DK · contact PI
FGF-23 Regulation of Phosphate Homeostasis$338,575
R01 · FY2012 · DK · contact PI
FGF-23 REGULATION OF PHOSPHATE HOMEOSTASIS$314,489
R01 · FY2011 · DK · contact PI
Conditional Isolation of Fgf23 Activity$199,584
R21 · FY2011 · AR · contact PI
FGF-23 REGULATION OF PHOSPHATE HOMEOSTASIS$317,666
R01 · FY2010 · DK · contact PI
Conditional Isolation of Fgf23 Activity$173,250
R21 · FY2010 · AR · contact PI
FGF-23 REGULATION OF PHOSPHATE HOMEOSTASIS$49,999
R01 · FY2010 · DK · contact PI
FGF-23 REGULATION OF PHOSPHATE HOMEOSTASIS$320,875
R01 · FY2009 · DK · contact PI
FGF-23 REGULATION OF PHOSPHATE HOMEOSTASIS$321,494
R01 · FY2008 · DK · contact PI
FGF-23 REGULATION OF PHOSPHATE HOMEOSTASIS$219,760
R01 · FY2007 · DK · contact PI
FGF-23 REGULATION OF PHOSPHATE HOMEOSTASIS$226,323
R01 · FY2006 · DK · contact PI
FGF-23 REGULATION OF PHOSPHATE HOMEOSTASIS$231,770
R01 · FY2005 · DK
FGF-23 REGULATION OF PHOSPHATE HOMEOSTASIS$231,770
R01 · FY2004 · DK
FGF-23 REGULATION OF PHOSPHATE HOMEOSTASIS$231,770
R01 · FY2003 · DK
POSITIONAL CLONING OF THE ADHR GENE$43,772
F32 · FY2001 · AR
POSITIONAL CLONING OF THE ADHR GENE$39,232
F32 · FY2000 · AR